Article
Application of an allele-specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patients.
Journal of medical virology - 1 Dec 2009
Carr Jillian M, Green Tara, Shaw David, Daly Lyndal, Hart Wendy, Ratcliff Rodney, Higgins Geoffrey, Burrell Christopher J, Li Peng, Qiao Ming
Abstract excerpt
Low-level drug resistance is not detected by routine consensus sequence genotype analysis (CSA) but low levels of specific mutations, such as the non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant mutation K103N, can be quantitated by allele-specific PCR (ASP). This study has applied an ASP to quantitate low-level K103N in patients presenting for clinical HIV genotyping and assess the correlation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
